Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Bupivacaine for Pain Control After Cleft Palate Repair in Children
NCT04928352Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- Jun 2021
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine in postoperative pain, sponsored by Assiut University. Started Jun 2021; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04928352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04928352.